作者: N. Khanna , A. F. Widmer , M. Decker , I. Steffen , J. Halter
DOI: 10.1086/525263
关键词: Mononegavirales 、 Ribavirin 、 Lower respiratory tract infection 、 Paramyxoviridae 、 Pneumovirus 、 Respiratory disease 、 Palivizumab 、 Immunology 、 Pneumovirinae 、 Medicine
摘要: Respiratory syncytial virus (RSV) causes significant mortality in patients with hematological diseases, but diagnosis and treatment are uncertain.